BioSpace News Archive

Asieris’ progress in MIBC receives renewed attention with its inclusion in ASCO 2023

Asieris Pharmaceuticals announced the phase I clinical data of ANTICIPATE Study was published for the first time at the 2023 American Society of Clinical Oncology annual meeting in Chicago.

May 31, 2023
·
3 min read
Genetown

Cellular Origins Launches Constellation, Its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies, has announced the launch of Constellation™, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy Annual Meeting 2023.

May 31, 2023
·
2 min read
Mereo BioPharma to Present at the 2023 Jefferies Healthcare Conference

Mereo BioPharma Group plc announced that Dr. Denise Scots-Knight, Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 09:30am ET / 01:30pm GMT.

May 31, 2023
·
4 min read
Genetown

EyePoint Pharmaceuticals to Present at the 2023 Jefferies Healthcare Conference

EyePoint Pharmaceuticals, Inc. announced that George Elston, Chief Financial Officer of EyePoint Pharmaceuticals, will present a company overview at the Jefferies Healthcare Conference on Wednesday, June 7, 2023 at 2:30 p.m. ET.

May 31, 2023
·
1 min read
Trevena Announces Receipt of Milestone Payment From Partner in China Jiangsu Nhwa Pharmaceutical

Trevena, Inc., a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system disorders, announced that it has received a $3 million milestone payment from its partner in China for the Chinese approval of OLINVYK.

May 31, 2023
·
13 min read
Biotech Bay

Qbiotics to Present at Sachs 9th Annual Immuno-Oncology Innovation Forum and the Bio International Convention

QBiotics Group Limited is pleased to announce that Richard Godfrey will present to potential partners and investors at the Sachs 9th Annual Immuno-Oncology Innovation Forum and the BIO International Convention, both being held in the US through June 2023.

May 31, 2023
·
3 min read
Genetown

Theseus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference

Theseus Pharmaceuticals, Inc. announced that the company will participate in a live Fireside Chat at the Jefferies Healthcare Conference on June 8th at 10:30am ET.

May 31, 2023
·
1 min read
Silence Therapeutics to Present at the Jefferies Healthcare Conference

Silence Therapeutics plc today announced that the Company will present at the Jefferies Healthcare Conference on Wednesday, June 7th at 4:00 – 4:25 PM EDT.

May 31, 2023
·
1 min read
Pharm Country

Bristol Myers Squibb to Hold R&D Day on September 14

Bristol Myers Squibb (NYSE: BMY) today announced that the company will hold a Research & Development (R&D) Day in New York City on Thursday, September 14, 2023, at 9:00 a.m. Company executives will provide investors and analysts with an overview of the company’s R&D strategy and pipeline opportunities.

May 31, 2023
·
1 min read
Genetown

Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych Congress

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, is presenting pivotal trial data on EndeavorRx at the Elevate Psych Congress in Las Vegas on June 2-3, 2023.

May 31, 2023
·
8 min read